Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 4 Planned sale President and COO sold 23,762 shares at an average $29.82 ($708,558)
  4. 4 Planned sale President and COO sold 35,643 shares at an average $26.78 ($954,442)
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 4 Planned sale President and COO sold 35,643 shares at an average $26.06 ($928,891)
  8. 4 Planned sale President and COO sold 35,643 shares at an average $28.00 ($998,097)
  9. 4 Planned sale President and COO sold 35,643 shares at an average $25.18 ($897,457)
  10. 4 Planned sale President and COO sold 35,643 shares at an average $24.66 ($879,088)
  11. 4 Planned sale President and COO sold 35,643 shares at an average $25.18 ($897,356)
  12. 4 Planned sale President and COO sold 35,643 shares at an average $25.81 ($919,870)
  13. 4 Planned sale President and COO sold 35,643 shares at an average $26.60 ($948,223)
  14. 4 Planned sale Chief Commercial Officer, MRD sold 6,444 shares at $30.00 ($193,320)
  15. 144 Insider Sale of Securities
  16. 4 Planned sale President and COO sold 35,643 shares at an average $28.46 ($1,014,329)
  17. 4 Planned sale Chief People Officer sold 26,792 shares at an average $28.28 ($757,697)
  18. 144 Insider Sale of Securities
  19. 4 Planned sale Chief People Officer sold 115,406 shares at an average $28.06 ($3,238,004)
  20. 4 Planned sale Chief Commercial Officer, MRD sold 1,195 shares at $27.00 ($32,265)

Page 1 of 42 · 836 filings